A Master Protocol to Evaluate Biomarker-Driven Therapies and Immunotherapies in Previously Treated NonSmall Cell Lung Cancer (LUNGMAP)
A Master Protocol to Evaluate Biomarker-Driven Therapies and Immunotherapies in Previously Treated NonSmall Cell Lung Cancer (LUNGMAP)
Trial Category:
Lung
Contact(s)
Location(s)
Faith Regional Health System, Carson Cancer Center, Norfolk, NE
Great Plains Health, Callahan Cancer Center, North Platte, NE
Nebraska Cancer Specialists, Omaha, NE
Nebraska Hematology Oncology, Lincoln, NE
Regional West Health Services, Cancer Center, Scottsbluff, NE
Southeast Nebraska Cancer Center, Lincoln, NE
This study will screen patients with lung cancer by using a piece of tumor from a previous biopsy or surgery, and testing it for specific biomarkers, and then connecting patients to specific new drug trials based on their biomarkers. Patients can be screened while being treated, or at the time of a tumor return.
